The study on the global intracranial stents market offers an incisive assessment of key demand dynamics, emerging trends, major clinical advancements, promising avenues, and the competitive landscape in various regions.
The global intracranial stents market is projected to clock a promising, double-digit CAGR from 2018 to 2026. Rapidly aging world populations and the rising preference of less invasive techniques for managing vascular malformation are notable factors bolstering the prospects of the intracranial stents market.
Relentless industry efforts to bring technological advancements has set the pace of innovation in the intracranial stents market over the past several years. Rising acceptance of intracranial stents for treating intracranial stenosis among clinicians is boosting the market. The market has also been propelled by the rising use of better intracranial stents in managing strokes. Considerable research in understanding the epidemiology and etiology of chronic neurological diseases bodes well for the intracranial stents market. Moreover, the market has witnessed large momentum from technological advances in self-expanding stents and steady improvements in stents in relation to their flexibility.
The advent of embolic devices has fueled the prospects of the market. Rising incidence of intracranial atherosclerosis disease in various parts of the world is a notable factor boosting the market. Rise in health care expenditure in developing countries and favorable government initiatives are helping bolster the overall prospects of the market. This has paved the way for the acceptance of advanced devices. For instance, favorable reimbursement scenario in developing and developed nations are catalyzing the growth.
Get a Sample PDF with detailed Market Insights: https://www.researchmoz.us/enquiry.php?type=S&repid=2117341
Of the various types of disease indications, intracranial stenosis is expected to account for the major share by the end of 2026. This is attributed to rapid technological advances in neurology care devices.
On the regional front, North America is expected to contribute a major share in the global intracranial stents market. The prominence is attributed to the presence of several key players in the region. The growth is expected to be fueled by rapid uptake of advanced health care technologies and increased awareness about the effectiveness of stents in patient populations. On the other hand, Asia Pacific is expected to create new avenues in the global market. The promising potential it holds is on the account of improving health care infrastructure and growing awareness about neurology disorders.
Some of the prominent players operating in the intracranial stents market are Cook Medical Incorporated, Terumo Corporation, Johnson & Johnson Services, Inc., Medtronic plc, Stryker Corporation, Penumbra, Inc., and Boston Scientific Corporation.